Fulcrum Therapeutics, Inc. (FULC) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80M | 0 | 871K | 759K | 880K | 295K | 685K | 1.18M | 1.88M | 2.59M | 5.06M | 4.93M | 4.38M |
| Revenue Growth % | - | - | - | -100% | - | -100% | -100% | 8990.91% | -100% | 27.15% | -35.84% | -53.24% | -88.62% | -86.46% | -76.03% | -57.04% | -45.88% | 19.72% | 167.05% | 119.05% |
| Cost of Goods Sold | 0 | -300K | 0 | 300K | 0 | 369K | 0 | 17.26M | 479K | 508K | 18.24M | 17.85M | 16.71M | 18.57M | 15.37M | 25.02M | 17.83M | 18.91M | 17.08M | 17.38M |
| COGS % of Revenue | - | - | - | - | - | - | - | 21.58% | - | 58.32% | 2402.9% | 2028.3% | 5666.1% | 2710.36% | 1298.9% | 1329.38% | 687.92% | 373.9% | 346.04% | 396.67% |
| Gross Profit | 0 | 300K | 0 | -300K | 0 | -369K | 0 | 62.74M | -479K | 363K | -17.48M | -16.97M | -16.42M | -17.88M | -14.18M | -23.14M | -15.24M | -13.85M | -12.14M | -13M |
| Gross Margin % | - | - | - | - | - | - | - | 78.42% | - | 41.68% | -2302.9% | -1928.3% | -5566.1% | -2610.36% | -1198.9% | -1229.38% | -587.92% | -273.9% | -246.04% | -296.67% |
| Gross Profit Growth % | - | 181.3% | - | -100.48% | 100% | -201.65% | 100% | 469.73% | 97.08% | 102.03% | -23.24% | 26.66% | -7.75% | -29.07% | -16.81% | -78.02% | -32% | -16.22% | 11.96% | -20.62% |
| Operating Expenses | 22.19M | 22.99M | 21.86M | 19.52M | 20.4M | 19.06M | 25.13M | 10.25M | 29.36M | 28.36M | 9.96M | 10.32M | 11.52M | 10.09M | 10.17M | 11.1M | 10.76M | 9.71M | 8.63M | 6.68M |
| OpEx % of Revenue | - | - | - | - | - | - | - | 12.81% | - | 3255.45% | 1312.38% | 1173.07% | 3905.08% | 1473.28% | 859.85% | 589.69% | 415.08% | 191.87% | 174.83% | 152.59% |
| Selling, General & Admin | 8.1M | 7.28M | 7.56M | 6.83M | 7M | 7.72M | 8.42M | 10.25M | 10.06M | 9.36M | 9.96M | 10.32M | 11.52M | 10.13M | 9.71M | 11.1M | 10.76M | 9.71M | 8.63M | 6.68M |
| SG&A % of Revenue | - | - | - | - | - | - | - | 12.81% | - | 1074.17% | 1312.38% | 1173.07% | 3905.08% | 1478.83% | 820.54% | 589.69% | 415.08% | 191.87% | 174.83% | 152.59% |
| Research & Development | 14.08M | 15.42M | 14.3M | 12.99M | 13.4M | 11.34M | 14.64M | 17.26M | 19.29M | 19M | 18.24M | 17.85M | 16.71M | 18.57M | 15.37M | 25.02M | 17.83M | 18.91M | 17.08M | 17.38M |
| R&D % of Revenue | - | - | - | - | - | - | - | 21.58% | - | 2181.29% | 2402.9% | 2028.3% | 5666.1% | 2710.36% | 1298.9% | 1329.38% | 687.92% | 373.9% | 346.04% | 396.67% |
| Other Operating Expenses | 0 | 300K | 0 | -300K | 0 | 0 | 1000K | -1000K | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -22.19M | -22.69M | -21.86M | -19.82M | -20.4M | -19.43M | -25.13M | 52.49M | -29.83M | -27.99M | -27.44M | -27.29M | -27.94M | -27.97M | -24.36M | -34.23M | -26M | -23.56M | -20.77M | -19.68M |
| Operating Margin % | - | - | - | - | - | - | - | 65.61% | - | -3213.78% | -3615.28% | -3101.36% | -9471.19% | -4083.65% | -2058.75% | -1819.08% | -1003.01% | -465.78% | -420.87% | -449.26% |
| Operating Income Growth % | -8.74% | -16.8% | 13.01% | -137.75% | 31.61% | 30.59% | 8.43% | 292.33% | -6.78% | -0.07% | -12.67% | 20.28% | -7.47% | -18.74% | -17.26% | -73.94% | -52.54% | -32.45% | -8.72% | -23.6% |
| EBITDA | -22.19M | -22.35M | -21.51M | -19.47M | -20.05M | -19.06M | -24.76M | 52.87M | -29.36M | -27.48M | -26.91M | -26.73M | -27.37M | -27.38M | -23.74M | -33.56M | -25.46M | -22.94M | -20.15M | -19.01M |
| EBITDA Margin % | - | - | - | - | - | - | - | 66.09% | - | -3155.45% | -3545.32% | -3036.93% | -9279.32% | -3997.37% | -2007.1% | -1783.16% | -982.33% | -453.5% | -408.33% | -433.92% |
| EBITDA Growth % | -10.65% | -17.24% | 13.11% | -136.83% | 31.7% | 30.65% | 8% | 297.82% | -7.24% | -0.37% | -13.33% | 20.36% | -7.51% | -19.37% | -17.83% | -76.53% | -54.88% | -34.5% | -8.63% | -23.67% |
| D&A (Non-Cash Add-back) | 0 | 347K | 346K | 344K | 353K | 369K | 369K | 376K | 479K | 508K | 531K | 567K | 566K | 591K | 611K | 676K | 536K | 621K | 619K | 672K |
| EBIT | 0 | -20.33M | -19.59M | -17.3M | -20.4M | -16.57M | -23.06M | 52.49M | -29.83M | -27.99M | -27.44M | -27.29M | -27.94M | -28.01M | -23.89M | -34.23M | -26M | -23.56M | -20.77M | -19.68M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.29M | 2.36M | 2.26M | 2.52M | 2.75M | 2.86M | 3.43M | 2.92M | 2.96M | 3.24M | 3.42M | 3.51M | 3.16M | 1.84M | 617K | 165K | 70K | 75K | 54K | 34K |
| Pretax Income | -18.89M | -20.33M | -19.59M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M |
| Pretax Margin % | - | - | - | - | - | - | - | 69.26% | - | -2842.25% | -3164.3% | -2702.61% | -8399.66% | -3815.33% | -2006.59% | -1810.31% | -1000.31% | -464.29% | -419.78% | -448.48% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -18.89M | -20.33M | -19.59M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M |
| Net Margin % | - | - | - | - | - | - | - | 69.26% | - | -2842.25% | -3164.3% | -2702.61% | -8399.66% | -3815.33% | -2006.59% | -1810.31% | -1000.31% | -464.29% | -419.78% | -448.48% |
| Net Income Growth % | -7% | -22.73% | 9.68% | -131.22% | 34.29% | 33.07% | 9.66% | 332.98% | -8.44% | 5.28% | -1.18% | 30.19% | 4.43% | -11.29% | -14.59% | -73.4% | -52.53% | -32.53% | -9.25% | -25.27% |
| Net Income (Continuing) | -18.89M | -20.33M | -19.59M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.87 | -0.43 | -0.40 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| EPS Growth % | 10.71% | 0% | 11.43% | -132.18% | 34.88% | 22.5% | 10.26% | 328.95% | -19.44% | 11.11% | 25% | 54.22% | 43.75% | 22.41% | 8.77% | -38.33% | -18.52% | 9.38% | 18.57% | 9.09% |
| EPS (Basic) | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.89 | -0.43 | -0.40 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| Diluted Shares Outstanding | 76.22M | 63.35M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 63.59M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M |
| Basic Shares Outstanding | 76.22M | 63.35M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 62.2M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |